![Lars Håkan Olsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Håkan Olsson
Président chez Belina Pharma AB
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Börje Soini Haraldsson | M | - |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | 11 ans |
Per Nellgård | M | - | 3 ans | |
Thomas Fabo | M | - | 2 ans | |
Björn Ingemar Odlander | M | 66 |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | - |
Andreas Segerros | M | 63 |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | - |
Magnhild Sandberg-Wollheim | F | 87 |
Lund University Hospital
| - |
Lars Åke Alvar Lidgren | M | 81 |
Lund University Hospital
| - |
Jacob Nejtel Kaluski | M | 73 |
Belina AB
| 6 ans |
Bo Ahrén | M | 72 |
Lund University Hospital
| 24 ans |
Lars Göran Leonardsson | M | - |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | - |
Lena Mårtensson Wernrud | M | 70 |
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | - |
Jan Talts | M | 59 |
Lund University Hospital
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Cecilia Jinert Johansson | F | 61 | - | |
Matti Reinikainen | M | - | - | |
Klas Rune Arildsson | M | 64 | 1 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Suède | 15 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Lars Håkan Olsson
- Réseau Personnel